🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to compare the efficacy and safety of venetocl...
Status
Completed
Location
Chinese PLA General Hospital
Start Date
2023-03-01
Trial ID
NCT06068621
Ziftomenib is an investigational drug in development for the treatment of p...
Status
Recruiting
Location
Mayo Clinic - Phoenix
Start Date
2023-07-18
Trial ID
NCT05735184
Treatments Being Tested
This is a Phase 1b, open-label study evaluating Venetoclax in combination w...
Status
Recruiting
Location
Montefiore Einstein Cancer Center and Children's Hospital at Montefiore (CHAM)
Start Date
2022-05-25
Trial ID
NCT05342584
Treatments Being Tested
This study evaluates the efficacy and safety of the combination of idarubic...
Status
Recruiting
Location
The First Affiliated Hospital with Nanjing Medical University
Start Date
2024-01-01
Trial ID
NCT06232694
This research is being done to assess the therapeutic efficacy and safety o...
Status
Active Not Recruiting
Location
The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology
Start Date
2022-03-01
Trial ID
NCT05177731
Treatments Being Tested
This is a Phase 1 clinical study designed to evaluate the safety, tolerabil...
Status
Recruiting
Location
Department of Hematology, the Fifth Medical Center of Chinese PLA General Hospital
Start Date
2025-12-01
Trial ID
NCT07297173
Treatments Being Tested
This phase I trial tests the safety, side effects, and best dose of venetoc...
Status
Active Not Recruiting
Location
City of Hope Medical Center
Start Date
2022-03-17
Trial ID
NCT05157971
This research study investigates the tolerability of substituting two cycle...
Status
Recruiting
Location
Texas Children's Cancer and Hematology Center
Start Date
2025-10-22
Trial ID
NCT07059975
The goal of this clinical trial is to estimate the rate (probability) of co...
Status
Recruiting
Location
First Affiliated Hospital Of University of Science and Technology of China
Start Date
2024-01-01
Trial ID
NCT06221683
This open-label, non-randomized, phase II exploratory study aims to evaluat...
Status
Recruiting
Location
Blood diseases hospital
Start Date
2026-05-30
Trial ID
NCT07454226